Foresee Pharmaceuticals Co (ROCO:6576) Cyclically Adjusted Book per Share: NT$10.24 (As of Dec. 2025)


ROCO:6576 Foresee Pharmaceuticals Co Ltd ROCO:6576
58 GF Score
Price NT$83.10
GF Value NT$96.69
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Foresee Pharmaceuticals Co Cyclically Adjusted Book per Share?

Foresee Pharmaceuticals Co ROCO:6576 58 Cyclically Adjusted Book per Share is NT$10.24 as of Dec. 2025. GuruFocus rates ROCO:6576 with a GF Score™ of 58/100 and a GF Value™ of NT$96.69 (Modestly Undervalued). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Foresee Pharmaceuticals Co's adjusted book value per share for the three months ended in Dec. 2025 was NT$5.901. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is NT$10.24 for the trailing ten years ended in Dec. 2025.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-07-11), Foresee Pharmaceuticals Co's current stock price is NT$83.10. Foresee Pharmaceuticals Co's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2025 was NT$10.24. Foresee Pharmaceuticals Co's Cyclically Adjusted PB Ratio of today is 8.12.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of Foresee Pharmaceuticals Co was 8.50. The lowest was 6.54. And the median was 7.72.


Foresee Pharmaceuticals Co  (ROCO:6576) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Foresee Pharmaceuticals Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=83.10/10.24
=8.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of Foresee Pharmaceuticals Co was 8.50. The lowest was 6.54. And the median was 7.72.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Foresee Pharmaceuticals Co Cyclically Adjusted Book per Share Related Terms


Foresee Pharmaceuticals Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Foresee Pharmaceuticals Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Foresee Pharmaceuticals Co Cyclically Adjusted Book per Share Chart

Foresee Pharmaceuticals Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 10.24

Foresee Pharmaceuticals Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 10.13 10.36 10.24

ROCO:6576 vs ZTS, UTHR: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Foresee Pharmaceuticals Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Foresee Pharmaceuticals Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Foresee Pharmaceuticals Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Foresee Pharmaceuticals Co's Cyclically Adjusted PB Ratio falls into.


ROCO:6576
58GF Score
Foresee Pharmaceuticals Co Ltd ROCO:6576
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Foresee Pharmaceuticals Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Foresee Pharmaceuticals Co's adjusted Book Value per Share data for the three months ended in Dec. 2025 was:

Adj_Book= Book Value per Share /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=5.901/324.0540*324.0540
=5.901

Current CPI (Dec. 2025) = 324.0540.

Foresee Pharmaceuticals Co Quarterly Data

Book Value per Share CPI Adj_Book
201512 4.907 236.525 6.723
201606 9.522 241.018 12.803
201609 0.000 241.428 0.000
201612 7.082 241.432 9.506
201703 0.000 243.801 0.000
201706 9.496 244.955 12.562
201709 8.237 246.819 10.815
201712 7.197 246.524 9.460
201803 6.006 249.554 7.799
201806 8.509 251.989 10.942
201809 7.194 252.439 9.235
201812 5.393 251.233 6.956
201903 5.030 254.202 6.412
201906 11.243 256.143 14.224
201909 9.548 256.759 12.050
201912 8.693 256.974 10.962
202003 7.673 258.115 9.633
202006 6.303 257.797 7.923
202009 5.285 260.280 6.580
202012 15.467 260.474 19.242
202103 14.159 264.877 17.322
202106 13.838 271.696 16.505
202109 12.466 274.310 14.727
202112 11.067 278.802 12.863
202203 10.151 287.504 11.441
202206 10.446 296.311 11.424
202209 9.253 296.808 10.102
202212 7.619 296.797 8.319
202303 6.242 301.836 6.701
202306 13.212 305.109 14.032
202309 11.595 307.789 12.208
202312 9.161 306.746 9.678
202403 8.458 312.332 8.775
202406 7.356 314.175 7.587
202409 5.146 315.301 5.289
202412 10.330 315.605 10.607
202503 8.580 319.799 8.694
202506 6.276 322.561 6.305
202509 6.749 324.800 6.733
202512 5.901 324.054 5.901

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of NT$10.24 mean?
Foresee Pharmaceuticals Co (ROCO:6576) has a Cyclically Adjusted Book per Share of NT$10.24 as of Dec. 2025. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Foresee Pharmaceuticals Co and its competitors.
Is Foresee Pharmaceuticals Co's Cyclically Adjusted Book per Share too high?
Foresee Pharmaceuticals Co's current Cyclically Adjusted Book per Share is NT$10.24. Overall, Foresee Pharmaceuticals Co has a GF Score™ of 58/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Foresee Pharmaceuticals Co's Cyclically Adjusted Book per Share compare to ZTS and UTHR?
Foresee Pharmaceuticals Co's Cyclically Adjusted Book per Share of NT$10.24 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Foresee Pharmaceuticals Co and its competitors. Foresee Pharmaceuticals Co's current Cyclically Adjusted Book per Share is NT$10.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Foresee Pharmaceuticals Co stock overvalued right now?
Based on GuruFocus' analysis, Foresee Pharmaceuticals Co (ROCO:6576) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$96.69, compared to a current price of NT$83.10 — trading 14.1% below its estimated fair value. The current Cyclically Adjusted Book per Share is NT$10.24. Foresee Pharmaceuticals Co's overall GF Score™ is 58/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Foresee Pharmaceuticals Co (ROCO:6576), the current Cyclically Adjusted Book per Share is NT$10.24 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Foresee Pharmaceuticals Co (ROCO:6576) Overvalued in 2026?

Based on GuruFocus' analysis, Foresee Pharmaceuticals Co stock appears to be undervalued. The current stock price of NT$83.10 is trading 14.1% below its estimated GF Value™ of NT$96.69. GuruFocus considers Foresee Pharmaceuticals Co to be Modestly Undervalued.

Key valuation signals for ROCO:6576:

  • Cyclically Adjusted Book per Share: NT$10.24
  • GF Value™: NT$96.69 vs. price of NT$83.10 (14.1% below fair value)
  • GF Score™: 58/100 with 7 warning signs

No single metric tells the full story. See the ROCO:6576 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Foresee Pharmaceuticals Co Business Description

Address No. 19-3, Sanchong Road, 9th Floor-2, Nangang District, Taipei, TWN, 115
Foresee Pharmaceuticals Co Ltd main activity is applying stabilized injectable formulation (SIF) platform technology to produce products for anticancer and treatment of chronic diseases. Its pipeline includes CAMCEVI (Leuprolide, FP-001), FP-014 (Triptorelin), Aderamastat (FP-025, MMP-12 Inhibitor), Linvemastat (FP-020, MMP-12 Inhibitor), and others. The Group operates business only in a single industry of new drug development, and all of its revenue is generated from Taiwan.
58GF Score

Get the complete analysis for ROCO:6576

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$83.10
Price
NT$96.69
GF Value